James W. Newman Jr. - 30 Dec 2021 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADIL	Common Stock	Purchase	$26,600	+10,000	+100%	$2.66	20,000	30 Dec 2021	Direct	F1
transaction	ADIL	Common Stock	Purchase	$13,600	+5,000	+11%	$2.72	50,221	30 Dec 2021	Ivy Cottage Group, LLC	F5
transaction	ADIL	Common Stock	Purchase	$27,100	+10,000	+41%	$2.71	34,644	30 Dec 2021	Roth IRA FBO James W Newman, Jr.	F6, F8
holding	ADIL	Common Stock						34,475	30 Dec 2021	Roundtop Limited Partnership, LLP	F2
holding	ADIL	Common Stock						41,160	30 Dec 2021	Newman GST Trust FBO James W. Newman Jr.	F3
holding	ADIL	Common Stock						152,963	30 Dec 2021	Virga Ventures, LLC	F4
holding	ADIL	Common Stock						5,000	30 Dec 2021	Courtney Newman	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.628 to $2.68, inclusive. The reporting person undertakes to provide Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (6) of this Form 4.
F2	James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
F3	James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
F4	James W. Newman is the sole member of Virga Ventures, LLC.
F5	James W. Newman is the general partner of Ivy Cottage Group, LLC.
F6	The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.655 to $2.72, inclusive.
F7	James W. Newman is the beneficiary of this Roth IRA.
F8	Courtney Newman is the daughter of James W. Newman, Jr.